These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23912823)

  • 1. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis.
    Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Inazawa N; Tsutsumi H; Suzuki N
    Indian J Pediatr; 2014 Mar; 81(3):288-91. PubMed ID: 23912823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndrome.
    Chi S; Ikezoe T; Takeuchi A; Takaoka M; Yokoyama A
    Int J Hematol; 2013 Nov; 98(5):615-9. PubMed ID: 24101336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation.
    Uni M; Yoshimi A; Maki H; Maeda D; Nakazaki K; Nakamura F; Fukayama M; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(6):1190-4. PubMed ID: 23696942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
    Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Rarity and Severity in an Immunocompetent Adult].
    Costa A; Paixão A; Santos H; Salvador F
    Acta Med Port; 2019 Feb; 32(1):78-80. PubMed ID: 30753807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
    Tamura K; Saito H; Asakura H; Okamoto K; Tagawa J; Hayakawa T; Aoki N
    Int J Clin Oncol; 2015 Aug; 20(4):821-8. PubMed ID: 25385713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
    Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
    Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
    Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
    Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
    Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
    Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
    Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
    Kotake K; Hongo T; Tahira A; Niimi N; Haisa I; Kawakami Y
    Biol Pharm Bull; 2021 May; 44(5):605-610. PubMed ID: 33612566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
    Kobayashi T; Kajiki M; Nihashi K; Honda G
    Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
    Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
    Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
    Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
    J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
    Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
    Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.